Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
The point-of-care diagnostics devices and equipment market has experienced significant growth recently, driven by technological advances and shifting healthcare needs. As rapid, on-site testing becomes more vital in managing patient care, this sector is on track for continued expansion. Let’s explore the current market size, key growth drivers, leading companies, emerging trends, and regional insights shaping this dynamic industry.
Point-of-Care Diagnostics Devices and Equipment Market Size and Growth Outlook
The market for point-of-care diagnostics devices and equipment has expanded swiftly in recent years. It is projected to grow from $64.11 billion in 2025 to $71.62 billion in 2026, representing a compound annual growth rate (CAGR) of 11.7%. This progress during the historic period can be attributed to the increasing prevalence of chronic diseases, rising demand for faster clinical decision-making, growth of outpatient healthcare services, greater use of portable diagnostic tools, and a surge in preventive healthcare adoption. Moving forward, the market is expected to accelerate further, reaching $118.72 billion by 2030 with a CAGR of 13.5%. This anticipated boost is fueled by growing interest in home healthcare diagnostics, expansion of digital health ecosystems, broader infectious disease screening initiatives, integration of AI-assisted diagnostic support, and heightened emphasis on remote patient monitoring. Key trends during the forecast period include the rapid uptake of quick diagnostic tests, rising popularity of decentralized diagnostic solutions, increasing use of connected point-of-care platforms, growth in home-based testing options, and a focus on user-friendly device designs.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2387&type=smp
The Role of Mobile Health Technology in Market Expansion
One of the primary factors driving the growth of the point-of-care diagnostics devices market is the rising adoption of mobile health (mHealth) technologies. These technologies utilize mobile devices like smartphones and tablets, alongside wireless wearables, to deliver healthcare services, disseminate information, and monitor health data in real time. Point-of-care diagnostic devices are essential to mHealth as they provide fast, convenient testing and data collection near the patient’s location, often integrating with mobile apps or smartphone platforms for efficient data management and sharing. For example, in February 2025, PharmiWeb reported that about 23% of healthcare interactions are expected to occur virtually, highlighting how mobile health adoption boosts demand for connected diagnostic devices.
Growing Importance of Mobile Health for Convenient Testing
Mobile health technology not only supports rapid diagnostics but also enhances accessibility and patient engagement by allowing testing to be performed outside traditional clinical settings. This shift responds to the increasing need for convenient, on-the-go health monitoring, particularly as outpatient and home-based healthcare gain traction. With advancements in wireless communication and device miniaturization, point-of-care devices are becoming more integrated and user-friendly, further propelling market growth.
Access The Complete Point-of-Care Diagnostics Devices And Equipment Market Report:
Detailed Market Segmentation and Opportunities in Point-of-Care Diagnostics
This market is divided into various segments to better understand product types, prescription methods, and end users. By product type, it includes infectious disease testing kits, cardiometabolic monitoring kits, cholesterol testing kits, pregnancy and fertility test kits, tumor or cancer markers, urinalysis testing kits, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, and other specialized types. Prescription mode segments comprise prescription-based testing devices and over-the-counter (OTC) testing devices. End users cover professional diagnostic centers, hospitals and critical care centers, outpatient healthcare settings, ambulatory care environments, research laboratories, and home use. Each segment contains further subcategories—for instance, infectious disease kits such as HIV, hepatitis, malaria, influenza, and COVID-19 testing kits; cardiometabolic kits including blood glucose and blood pressure monitors; and tumor marker kits like PSA and CA-125 tests, among others.
Innovative Trends Enhancing the Point-of-Care Diagnostics Market
Leading companies in the point-of-care diagnostics field are focusing on product innovation to improve healthcare access and reduce diagnostic times. A notable example is the launch of Cippoint in January 2023 by Cipla Limited, an India-based pharmaceutical firm. Cippoint is a sophisticated point-of-care testing device capable of analyzing multiple health parameters including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation factors. Utilizing immunofluorescence technology, it delivers results within 3 to 15 minutes, enabling faster clinical decision-making. The device is also designed for ease of use across various settings such as hospitals, clinics, and mobile healthcare vans, making it highly versatile.
Key Industry Players Defining the Competitive Landscape
Major companies shaping the point-of-care diagnostics devices and equipment market include Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Danaher, Beckman Coulter, Becton Dickinson and Company, Qiagen N.V., Johnson & Johnson, Alere, BioMerieux, Chembio Diagnostic Systems, Quidel Corporation, EKF Diagnostics, Trinity Biotech Plc, OraSure Technologies, Sysmex Corporation, Radiometer Medical ApS, Response Biomedical Corporation, Bio-Rad Laboratories, Illumina, Thermo Fisher Scientific Inc., LabCorp, Luminex Corporation, LifeScan, Nova, Sekisui Diagnostics, Hemocue AB, and Akers Biosciences. These organizations are driving innovation, expanding product portfolios, and strengthening their market presence globally.
Regional Insights Highlighting Market Leadership and Expansion
In 2025, North America is expected to hold the largest share of the point-of-care diagnostics devices and equipment market. Meanwhile, Asia-Pacific stands as the second-largest region and is anticipated to see significant growth due to increasing healthcare infrastructure investments and rising demand for diagnostic services. The broader market analysis encompasses regions such as Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive view of the global market landscape and emerging opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
